Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125210571 | 12521057 | 1 | I | 20160621 | 20160701 | 20160701 | EXP | US-JNJFOC-20160621915 | JOHNSON AND JOHNSON | HO TW, HO AP, GE Y, ASSAID C, GOTTWALD R, MACGREGOR EA, ET AL. RANDOMIZED CONTROLLED TRIAL OF THE CGRP RECEPTOR ANTAGONIST TELCAGEPANT FOR PREVENTION OF HEADACHE IN WOMEN WITH PERIMENSTRUAL MIGRAINE. CEPHALALGIA 2016;36(2):148-161. | 0.00 | A | F | Y | 0.00000 | 20160701 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125210571 | 12521057 | 1 | PS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | U | U | 19872 | UNKNOWN | ||||||||
125210571 | 12521057 | 2 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | U | U | 19872 | UNKNOWN | ||||||||
125210571 | 12521057 | 3 | SS | TELCAGEPANT | TELCAGEPANT | 1 | Unknown | U | 0 | 140 | MG | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125210571 | 12521057 | 2 | Product used for unknown indication |
125210571 | 12521057 | 3 | Pain prophylaxis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125210571 | 12521057 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125210571 | 12521057 | Drug-induced liver injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |